Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene.
Familial hypercholesterolemia
Genetic diagnosis
Low-density lipoprotein cholesterol
Low-density lipoprotein receptor
Proprotein convertase subtilisin/kexin type 9
Journal
Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298
Informations de publication
Date de publication:
01 Jun 2022
01 Jun 2022
Historique:
pubmed:
2
7
2021
medline:
7
6
2022
entrez:
1
7
2021
Statut:
ppublish
Résumé
The 2017 Japan Atherosclerosis Society (JAS) familial hypercholesterolemia (FH) criteria adopt a cut-off value of ≥ 9 mm of Achilles tendon thickness (ATT) detected by X-ray as one of the three key items. This threshold was determined based on an old data evaluating the ATT of 36 non-FH individuals that was published in 1977. Although the specificity of these clinical criteria is extremely high due to a strict threshold, there are a significant number of patients with FH whose ATT <9 mm. We aimed to determine a cut-off value of ATT detected by X-ray to differentiate FH and non-FH based on genetic diagnosis. The individuals (male/female=486/501) with full assessments of genetic analyses for FH-genes (LDLR and PCSK9), serum lipids, and ATT detected by X-ray at the Kanazawa University Hospital and National Cerebral and Cardiovascular Center Research Institute were included in this study. Receiver operating characteristic (ROC) analyses were conducted to determine a better cut-off value of ATT that predicts the pathogenic mutation of FH. The ROC analyses revealed that the best cut-off values of ATT are 7.6 mm for male and 7.0 mm for female, with the sensitivities/specificities of 0.83/0.83 for male and 0.86/0.85 for female, respectively. If the thresholds of ATT of 8.0/7.5 mm and 7.5/7.0 mm were applied to the diagnosis of male/female FH, the sensitivities/specificities predicting the pathogenic mutation of FH by the 2017 JAS FH clinical criteria would be 0.82/0.90 and 0.85/0.88, respectively. These results suggest that the cut-off value of ATT detected by X-ray is obviously lower than 9.0 mm, which was adopted by the 2017 JAS FH clinical criteria.
Identifiants
pubmed: 34193720
doi: 10.5551/jat.62869
pmc: PMC9174093
doi:
Substances chimiques
Receptors, LDL
0
PCSK9 protein, human
EC 3.4.21.-
Proprotein Convertase 9
EC 3.4.21.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
816-824Commentaires et corrections
Type : CommentIn
Références
Circulation. 2020 Jun 2;141(22):1742-1759
pubmed: 32468833
Circ Genom Precis Med. 2020 Aug;13(4):e000067
pubmed: 32698598
Atherosclerosis. 2001 Aug;157(2):514-8
pubmed: 11472754
J Atheroscler Thromb. 2010 Jul 30;17(7):667-74
pubmed: 20534948
N Engl J Med. 2019 Oct 17;381(16):1547-1556
pubmed: 31618540
J Am Coll Cardiol. 2018 Aug 7;72(6):662-680
pubmed: 30071997
J Clin Lipidol. 2021 Mar-Apr;15(2):358-365
pubmed: 33461934
J Clin Lipidol. 2020 May - Jun;14(3):346-351.e9
pubmed: 32331935
Pract Lab Med. 2020 Oct 19;22:e00180
pubmed: 33134466
Circulation. 2018 May 22;137(21):2218-2230
pubmed: 29581125
Circ J. 2017 Nov 24;81(12):1879-1885
pubmed: 28652530
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Eur Heart J. 2017 May 21;38(20):1573-1579
pubmed: 28159968
Atherosclerosis. 2019 Oct;289:101-108
pubmed: 31491741
Eur Heart J. 2013 Dec;34(45):3478-90a
pubmed: 23956253
J Atheroscler Thromb. 2018 Aug 1;25(8):751-770
pubmed: 29877295
Curr Opin Lipidol. 2017 Apr;28(2):120-129
pubmed: 28169869
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Am Coll Cardiol. 2020 May 26;75(20):2553-2566
pubmed: 32439005
J Clin Lipidol. 2018 Nov - Dec;12(6):1436-1444
pubmed: 30241732
Atherosclerosis. 1977 Sep;28(1):61-8
pubmed: 911369
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2203-8
pubmed: 16123315
J Atheroscler Thromb. 2017 Mar 1;24(3):189-207
pubmed: 28179607
Atherosclerosis. 2018 Oct;277:234-255
pubmed: 30270054
Atherosclerosis. 2015 Jun;240(2):324-9
pubmed: 25875382